- About GRP
- Resource Center
- RI Platform
- Contact Us
During the review of a premarket submission, FDA’s practice has been to communicate with applicants through either a formal communication (such as a Major Deficiency Letter or an additional information request issued through a letter, or through phone, fax, or email, with a follow-up letter confirming the hold) or through the process of Interactive Review.
Copyright ©2023 Global Regulatory Partners